This research proposes a method for separating and purifying tissue-type plasminogen activator from a fungal cell source.
DESIGN CELLS /STOCK.ADOBE.COM
This work was designed to establish methods for purifying a fibrinolytic enzyme with high purity and fibrinolytic activity from Trichoderma reesei-submerged culture liquid. Presently, the majority of tissue-type plasminogen activator (t-PA) is separated and purified from biological tissues or anima cells. Separation and purification of t-PA from genetically recombined T. reesei, a fungus, has not been reported. This research proposes a method for separating and purifying t-PA from this fungal cell source. The method, characterized by low cost, high activity recovery, and simple operation, can be applied in clinical settings.
Click
herefor a PDF of the article.
Submitted: April 10, 2018
Accepted: May 3, 2018
Jinhua Shao, Fulin He*, 18500327677@163.com, and Xiaoming Chen are at the School of Chemical and Biological Engineering, Hunan University of Science and Engineering; Yufei Zhang is at the Key Laboratory of Anti-fibrous Biological Therapy, MuDanjiang Medical University; and Zhiyong Zhu is at the College of Computer Science, Hunan University of Science and Engineering.
*To whom correspondence should be addressed.
BioPharm International
Volume 31, Issue 12
December 2018
Pages: 30–38
When referring to this article, please cite it as J. Shao et al., “Separation and Purification of a Tissue-Type Plasminogen Activator from Trichoderma reesei,” BioPharm International 31 (12) 2018.
Thermo Fisher Opens Advanced Therapies Collaboration Center in California
April 18th 2025The 6000-square-foot facility will provide cell therapy developers the support they need to transition to CGMP manufacturing, and an expanded footprint of the new center is expected to open in Philadelphia later in 2025.